Anti-CD20 monoclonal antibody therapies in relapsing multiple sclerosis: A systematic review and meta-analysis of randomised controlled trials. Alatawi A, Al-Dhahi A S, Alatawi A, Almaser S Mult Scler Relat Disord. 2026 Sep 09; 115:107919. PMID: 42785004. Abstract CommentRecommendBookmarkWatch